Abstract:Viral keratouveitis (VKU) could be visually debilitating owing to the intraocular inflammation causing collateral damage to the cornea and secondary elevation of intraocular pressure (IOP). In this retrospective, single-center, observational study, we analyze the clinical features and management options for VKU, with a brief review on incidence of glaucoma and its treatment outcomes. We reviewed the outpatient records at our tertiary hospital from 2015 to 2020 and found 53 eyes of 55 patients diagnosed as VKU. The main outcome measures were incidence of clinical signs, elevated IOP and glaucoma, and treatment modalities used. Sixty-four percent were males with a mean age of onset being 45.4 years. Eighty percent of the eyes were clinically diagnosed to have herpes simplex virus (HSV), 16% herpes zoster virus (HZV) and 4% cytomegalovirus (CMV). Ocular presentations most commonly noted were keratic precipitates (70.4%), corneal edema (66.7%). Associated elevation of IOP was seen in 24 eyes (44%), while glaucomatous damage was seen in 20% of the eyes. Those with fewer uveitic episodes (less than two), as opposed to those having more than two episodes (p < 0.09) posed a lesser risk of developing glaucoma. Almost all were treated with topical steroids and oral acyclovir. The need for glaucoma surgery, in our study, was only 7.2%. Majority of patients with glaucoma, as compared to those without, appeared to have a higher number of IOP spikes and uveitic episodes. CMV-associated eyes had higher risk of developing glaucoma and were more intractable, requiring more intense treatment strategies. This review of the clinical profile of an exclusive South Indian cohort of VKU with an attempt to understand the differences in presentation between the herpetic and CMV groups and its implication from a glaucoma perspective makes this study distinctive. How to cite this article: Sudhakar P, Menon M, CK M, et al. Glaucoma in Viral Keratouveitis: A Retrospective Review at a Tertiary Eye Hospital. J Curr Glaucoma Pract 2022;16(1):65-70.

Ayurveda Management of Viral Conjunctivitis (Raktaja Abhishyanda) – A Case Report

Conjunctivitis: Diagnosis and Management

Understanding conjunctivitis: Symptoms, Causes, and Treatment

Acute Conjunctivitis among Patients Visiting the Outpatient Department of Ophthalmology in a Tertiary Care Centre

A Clinical Case of Viral Keratitis

Role of Ayurveda in the Management of Central Retinal Vein Occlusion- A Case Report

Conjunctivitis : health awareness

Epidemiology of Keratoconjunctivitis Across India from 2017 to 2019: A Multicentric Hospital-Based Study

Conjunctivitis as the only sign and symptom of COVID-19: A case report and review of literature

CONJUNCTIVITIS INFECTION: A BRIEF REVIEW ON ITS CLASSIFICATION, ETIOLOGY AND THERAPEUTIC INTERVENTIONS

Viral Conjunctivitis Rates Unchanged Before and During the COVID-19 Pandemic in an Ophthalmology Clinic

Relapsing viral keratoconjunctivitis in COVID-19: a case report

Viral Keratitis, Surgical Intervention in Viral Keratitis, Challenges in Diagnosis and Treatment of Viral Keratitis, HSV, HZV

Glaucoma in Viral Keratouveitis: A Retrospective Review at a Tertiary Eye Hospital

Viral Anterior Uveitis: A Practical and Comprehensive Review of Diagnosis and Treatment

Occurrence of Bacterial Conjunctivitis and Viral Conjunctivitis in Pakistan

Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: A retrospective cross-sectional study

Keeping an eye on pink eye: a global conjunctivitis outbreak expert survey

COVID-19 and the Human Eye: Conjunctivitis, a Lone COVID-19 Finding – A Case-Control Study

Pediatric Conjunctivitis: A Review of Clinical Manifestations, Diagnosis, and Management

Acute Onset of Bilateral Follicular Conjunctivitis in two Patients with Confirmed SARS-CoV-2 Infections